Contract 75A50119C00062
Partner Therapeutics, Inc. · Department Of Health And Human Services · September 16, 2019
Partner Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 16, 2019 for $55.00 million of work in pharmaceutical preparation manufacturing. Performance is in Lexington, MA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 15, 2022.
Contract details
- PIID
- 75A50119C00062
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Chemical And Pharmaceutical Products Manufacturing Machinery
- Place of performance
- Lexington, MA
- First action
- September 16, 2019
- Latest action
- February 15, 2022
Description
LEUKINE 250MCG/VIL INJ 186,440
Modification timeline
-
February 15, 2022Mod P00001$0
-
September 16, 2019Base award$55.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50119C00062?
Contract 75A50119C00062 is a federal contract awarded to Partner Therapeutics, Inc. by Department Of Health And Human Services on September 16, 2019 for $55.00 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75A50119C00062?
Partner Therapeutics, Inc. won contract 75A50119C00062 from Department Of Health And Human Services.
How much is contract 75A50119C00062 worth?
Contract 75A50119C00062 has obligated $55.00 million to date.